-
Mashup Score: 2Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium–glucose cotransporter 2 inhibitors - 11 month(s) ago
Abstract. Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of major heart failure events, an action that is statistically linked to enhanced er
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium–glucose cotransporter 2 inhibitors - 12 month(s) ago
Abstract. Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of major heart failure events, an action that is statistically linked to enhanced er
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium–glucose cotransporter 2 inhibitors - 1 year(s) ago
Abstract. Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of major heart failure events, an action that is statistically linked to enhanced er
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3Luspatercept Improves Anemia After Five Years in Patients With Lower-Risk MDS | ASH Clinical News | American Society of Hematology - 1 year(s) ago
Skip Nav Destination November 21, 2022 Luspatercept therapy for patients with lower-risk myelodysplastic syndromes (MDS), including those with ring sideroblasts (RS) relapsed or refractory to erythropoietin, was associated with…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Erythropoietin Falls Short of Neuroprotection in Optic Neuritis - 3 year(s) ago
A higher rate of conversion to multiple sclerosis in the placebo group offered a glimmer of hope for treatment in TONE, a phase 3 randomized trial, but caveats loom large.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Background Anemia is a significant problem in patients on ICU. Its commonest cause, iron deficiency (ID), is difficult to diagnose in the context of inflammation. Hepcidin is a new marker of ID. We aimed to assess whether hepcidin levels would accurately guide treatment of ID in critically ill anemic patients after a prolonged ICU stay and affect the post-ICU outcomes. Methods In a controlled,…
Source: Critical CareCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 1
Therapeutic modulation of hypoxia-inducible factors, which transduce adaptive transcriptional responses to hypoxia, is an emerging theme in kidney disease. This Review summarizes the hypoxia signalling mechanisms underpinning these novel treatments and highlights key remaining questions relevant to their clinical use.
Source: Nature Reviews NephrologyCategories: Latest Headlines, NephrologyTweet
Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium–glucose cotransporter 2 inhibitors. Read more in #EHJ: https://t.co/iyCr0Htn6y #SGLT2i #erythropoietin #erythropoiesis #cardiotwitter @escardio @ESC_Journals https://t.co/PL1k7Ku1gA